Search results for "HEART"

showing 10 items of 3201 documents

Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricul…

1994

This study was designed to evaluate total (t) and surface (s) β-adrenergic receptor (BAR) density and their relationship with central haemodynamics and left ventricular function in young subjects with central or peripheral obesity. A total of 31 obese subjects (BMI ≥30.5 kg. m−2 for males and >27.3 kg. m−2 for females) aged less than 40 years and without other risk factors for cardiovascular diseases (smoking, hypertension, diabetes and lipid abnormalities) were studied. Nine had peripheral obesity and 22 central obesity according to WHR values; there were 20 lean controls (BMI <25 kg. m−2 for males and <24.7 kg. m−2 for females). Casual (c) and 24 h ambulatory mean blood pressures (MBP-24 …

AdultMalemedicine.medical_specialtyCardiac outputSettore MED/09 - Medicina InternaMegalencephalic leukoencephalopathy with subcortical cystsEpinephrineDiastoleHemodynamicsBlood volumeVentricular Function LeftBody Mass IndexNorepinephrineRisk FactorsInternal medicineDiabetes mellitusReceptors Adrenergic betamedicineHumansInsulinLymphocytesObesitySystoleRadionuclide ImagingEjection fractionbusiness.industryHemodynamicsHeartmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCardiovascular DiseasesEchocardiographyBody ConstitutionRegression AnalysisPeripheral obesity Central Obesity Lymphocyte beta adrenergic receptors left ventricular functionFemaleCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Haemodynamic effects of a single intravenous dose of lorcainide in patients with heart disease

1980

The cardiovascular effects of a single i.v. dose (2 mg/kg over 5 min) of lorcainide were studied in 14 patients with heart disease. In the haemodynamic part of the study (6 patients), the aortic and pulmonary systolic, diastolic and mean pressures, left ventricular systolic and end-diastolic pressures, cardiac output and the rate of rise of left ventricular pressure were measured before and for 30 min after administration of the drug. Lorcainide produced a slight and short-lasting decrease in the aortic and pulmonary systolic pressures, and all other pressure values remained unchanged. The cardiac output and systemic vascular resistance were not altered by lorcainide. It consistently depres…

AdultMalemedicine.medical_specialtyCardiac outputTime FactorsHeart DiseasesHeart diseaseBenzeneacetamidesDiastoleHemodynamicsBlood PressureLorcainidePiperidinesInternal medicinemedicineHumansPharmacology (medical)Cardiac OutputAgedPharmacologyEjection fractionbusiness.industryHeartGeneral MedicineMiddle Agedmedicine.diseaseMyocardial Contractionmedicine.anatomical_structureAnesthesiaVascular resistanceVentricular pressureCardiologyFemaleVascular ResistancebusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Long-Term Enoximone Therapy in Unstable Chronic Heart Failure

1989

Long-term safety and efficacy of oral enoximone were evaluated in 32 patients with unstable chronic heart failure despite digitalis, diuretics, and vasodilator therapy. Oral enoximone, 75-150 mg t.i.d. was given for an average of 32 weeks. At baseline, 21 patients were in NYHA functional class IV, 10 patients in class III, and 1 patient in class II. Within 12 weeks, 14 of 20 patients surviving for more than 26 weeks had improved by at least one functional class. Hemodynamic data showed an 18% increase of cardiac index and a 34% decrease of diastolic pulmonary artery pressure. Echocardiographic recordings revealed an increase of fractional shortening from 13.9 +/- 7 to 15.6 +/- 5% after 12 w…

AdultMalemedicine.medical_specialtyCardiotonic AgentsHeart diseaseCardiac indexDiastoleSudden deathElectrocardiographyInternal medicinemedicine.arterymedicineHumansEnoximoneEnoximoneSurvival rateAgedAged 80 and overHeart FailurePharmacologybusiness.industryHemodynamicsImidazolesMiddle Agedmedicine.diseaseSurgeryHeart failureChronic DiseasePulmonary arteryCardiologyFemalebusinessCardiology and Cardiovascular Medicinemedicine.drugJournal of Cardiovascular Pharmacology
researchProduct

Case study: effect of handrim diameter on performance in a paralympic wheelchair athlete.

2009

This study, with a top T-52 class athlete, determines the relationship between stroke frequency (SF) and push time (PT) and wheelchair velocity (Wv) using different handrim diameters (HD) and the effect of different HDs on the athlete’s heart rate (HR) and blood lactate (LACT) at competition speeds. Wv shows a linear-direct relationship with SF but a linear-inverse relationship with PT (p &lt; .001 in both cases). Using bigger handrims (0.37 m instead of 0.36 m), SF increases 6%, while PT decreases 27% (at 24 Km·h–1). HR (p &lt; .0001) increases with Wv and is also affected by HD with differences between the 0.34 m—0.36 m handrim group (lower values) and the 0.37 m handrim (higher values). …

AdultMalemedicine.medical_specialtyCompetitive BehaviorInjury controlPoison controlPhysical Therapy Sports Therapy and RehabilitationMotor ActivityQuadriplegiaWheelchairAnimal scienceCharcot-Marie-Tooth DiseaseHeart RateAssistive technologyHeart rateTask Performance and AnalysisBlood lactatemedicineHumansDisabled PersonsMotor activitybusiness.industryStroke frequencyEquipment DesignBiomechanical PhenomenaWheelchairsPhysical therapybusinessSportsAdapted physical activity quarterly : APAQ
researchProduct

Skeletal muscle fibre types, enzyme activities and physical performance in young males and females

1978

Differences in skeletal muscle characteristics, metabolic profiles and functional performance between males and females were investigated using young (15--24 yrs) male and female twins as subjects. The comparison included such variables as anthropometry, muscle strength, mechanical power, maximum oxygen uptake, electrical activation of muscle, muscle fibre composition (m. vastus lateralis), and activities of several skeletal muscle enzymes. The results disclosed the following primary differences between males and females: In the various functional tests the performance of females was from 61.1 to 84.6% of that in males; distribution of slow twitch fibres in m. vastus lateralis of the female…

AdultMalemedicine.medical_specialtyContraction (grammar)AdolescentPhosphorylasesPhysiologyATPasePhysical ExertionTwinsIsometric exerciseBiologyIsozymeGlycogen phosphorylaseOxygen ConsumptionSex FactorsHeart RatePregnancyHexokinaseInternal medicinemedicineHumansGlycolysisCreatine KinaseAdenosine TriphosphatasesL-Lactate DehydrogenaseMusclesAdenylate KinaseSkeletal muscleVO2 maxIsoenzymesmedicine.anatomical_structureEndocrinologyPhysical FitnessLactatesbiology.proteinFemaleMuscle ContractionActa Physiologica Scandinavica
researchProduct

Influence of heart rate in the selection of the optimal reconstruction window in routine clinical multislice coronary angiography

2008

Purpose. The aim of our study was to assess the influence of heart rate on the selection of the optimal reconstruction window with 40-slice multidetector-row computed tomography (40-MDCT) coronary angiography. Materials and methods. We studied 170 patients (114 men, age 60 +/- 11.3 years) with suspected or known coronary artery disease with 40-MDCT coronary angiography. Patients [mean heart rate (HR) 62.9 +/- 9.3 bpm, range 42-94 bpm] were clustered in two groups (group A: HR &lt;= 65 bpm; group B: HR &gt;65 bpm). Multiphase reconstruction data sets were obtained with a retrospective electrocardiogram (ECG)-gated 40-MDCT coronary angiography scan from 0% to 95% every 5% of the R-R interval.…

AdultMalemedicine.medical_specialtyCoronary AngiographyHeart RateHeart rateImage Processing Computer-AssistedHumansMedicineRadiology Nuclear Medicine and imagingMultislicecardiovascular diseasesSelection (genetic algorithm)AgedNeuroradiologyAged 80 and overmedicine.diagnostic_testbusiness.industryUltrasoundWindow (computing)Interventional radiologyGeneral MedicineMiddle Agedcardiovascular systemFemaleTomographyRadiologyArtifactsTomography X-Ray ComputedbusinessRadiologia Medica
researchProduct

Refined atrial fibrillation screening and cost-effectiveness in the German population

2021

ObjectiveLittle is known on optimal screening population for detecting new atrial fibrillation (AF) in the community. We describe characteristics and estimate cost-effectiveness for a single timepoint electrocardiographic screening.MethodsWe performed a 12-lead ECG in the German population-based Gutenberg Health Study between 2007 and 2012 (n=15 010), mean age 55±11 years, 51% men and collected more than 120 clinical and biomarker variables, including N-terminal pro B-type natriuretic peptide (Nt-proBNP), risk factors, disease symptoms and echocardiographic variables.ResultsOf 15 010 individuals, 466 (3.1%) had AF. New AF was found in 32 individuals, 0.2% of the total sample, 0.5% of indivi…

AdultMalemedicine.medical_specialtyCost effectivenessCost-Benefit AnalysisPopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineAtrial FibrillationNatriuretic Peptide BrainEpidemiologyHumansMedicine030212 general & internal medicineRisk factoreducationStrokeAgedHeart Failureeducation.field_of_studybusiness.industryAtrial fibrillationMiddle Agedmedicine.diseasePeptide Fragments3. Good healthStrokeHeart failureBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersHeart
researchProduct

The distribution of whole blood viscosity, its determinants and relationship with arterial blood pressure in the community: cross-sectional analysis …

2015

Background: Blood viscosity has a role in modulating cardiovascular homeostasis; changes in this parameter have been associated with cardiovascular mortality and morbidity. However, it remains unclear whether these changes are (1) involved in the pathophysiology of disease, (2) an epiphenomenon, or (3) the expression of counterregulatory mechanisms. We report data on the normal values of blood viscosity and its association with cardiovascular risk factors, prevalent cardiovascular disease, and blood pressure in a large population-based cohort study. Methods and results: Viscosity was calculated using validated formulae and its associations were explored in 15,010 participants (mean 55.0, mi…

AdultMalemedicine.medical_specialtyCross-sectional studyBlood viscosityDiseaseCoronary Artery DiseaseRisk AssessmentReference ValuesRisk FactorsInternal medicineGermanymedicinePrevalenceHumansPharmacology (medical)Arterial PressureAgedHeart Failurebusiness.industryWhole blood viscosityRegression analysisMiddle AgedBlood ViscosityHealth SurveysPathophysiologySurgeryBlood pressureCross-Sectional StudiesLogistic ModelsCardiovascular DiseasesCohortCardiologyLinear ModelsFemaleCardiology and Cardiovascular MedicinebusinessTherapeutic advances in cardiovascular disease
researchProduct

Atrial Fibrillation Manifestations Risk Factors and Sex Differences in a Population-Based Cohort (From the Gutenberg Health Study)

2018

Sex differences in cardiovascular risk factors, cardiac structure and function, and disease and symptom burden in the common arrhythmia atrial fibrillation (AF) have not been investigated systematically at the population level. Cross-sectional data of 14,796 subjects (age range 35 to 74 years, 50.5% men) from the population-based Gutenberg Health Study were examined to show the distribution of cardiovascular risk factors by AF status and sex, and to determine sex-specific predictors for AF. The prevalence of AF was higher in men (4.3%) than in women (1.9%). Men had a worse cardiovascular risk factor profile, a higher prevalence of cardiovascular disease, but fewer symptoms than women. Age-a…

AdultMalemedicine.medical_specialtyCross-sectional studyHeart VentriclesPopulation030204 cardiovascular system & hematologyRisk AssessmentVentricular Function LeftCoronary artery diseaseElectrocardiography03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsGermanyInternal medicineAtrial FibrillationPrevalenceHumansMedicine030212 general & internal medicineMyocardial infarctionRisk factoreducationAgedRetrospective Studieseducation.field_of_studybusiness.industryIncidenceRetrospective cohort studyAtrial fibrillationOdds ratioMiddle Agedmedicine.disease3. Good healthSurvival RateCross-Sectional StudiesEchocardiographyPopulation SurveillanceCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe American Journal of Cardiology
researchProduct

Fabry disease: overall effects of agalsidase alfa treatment

2004

Background  Fabry disease is a rare X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A. Progressive accumulation of the substrate globotriaosylceramide in cells throughout the body leads to major organ failure and premature death. The Fabry Outcome Survey (FOS) is a European outcomes database which was established to collect data on the natural history of this little-known disease and to monitor the long-term efficacy and safety of enzyme replacement therapy (ERT) with agalsidase alfa. This paper presents the first analysis of the FOS database on the effects of ERT on renal function, heart size, pain and quality of life. Design  The effects of 1 and 2 y…

AdultMalemedicine.medical_specialtyDatabases FactualClinical BiochemistryGlobotriaosylceramidePainRenal functionBiochemistrychemistry.chemical_compoundQuality of lifeInternal medicineHumansMedicineEnlarged heartBrief Pain Inventorybusiness.industryVascular diseaseMyocardiumGeneral MedicineEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseaseRecombinant ProteinsSurgeryIsoenzymesTreatment Outcomechemistryalpha-GalactosidaseQuality of LifeFabry DiseaseFemaleHypertrophy Left VentricularbusinessFollow-Up StudiesGlomerular Filtration RateEuropean Journal of Clinical Investigation
researchProduct